Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT
NCT: NCT07711626 · RECRUITING
Brief Summary
Head and neck cancer (HNC) patients undergoing concurrent chemoradiotherapy (CCRT) frequently experience pain, xerostomia, fatigue, sleep disturbance, and other treatment-related toxicities that impair quality of life and treatment adherence, with incomplete relief from current supportive care. This randomized, single-blind, sham-controlled trial evaluates whether foot reflexology (FR), transcutaneous auricular vagus nerve stimulation (ta-VNS), and auricular acupressure (AA) reduce pain, xerostomia, fatigue, sleep disturbance, and treatment-related symptoms in HNC patients receiving cisplatin-based CCRT, compared with usual care. Participants are randomized to a foot reflexology group, an auricular vagus nerve stimulation group (each with true and sham subgroups), or a usual-care control group, and are followed at baseline and weeks 1, 2, and 4.
Frequently Asked Questions
What is Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT?
Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT is a clinical trial registered under NCT07711626. Current status: RECRUITING.
What is the status of NCT07711626?
The current status of NCT07711626 (Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT) is: RECRUITING.
When did Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT start?
Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT started on 2026-07-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.